Literature DB >> 18683379

Prevention of mother-to-child transmission of HIV programme: low vertical transmission in KwaZulu-Natal, South Africa.

Rosemary Geddes1, Stephen Knight, Sandy Reid, Janet Giddy, Tonya Esterhuizen, Candice Roberts.   

Abstract

OBJECTIVE: To describe the operational effectiveness of the prevention of mother-to-child transmission (PMTCT) of HIV programme at McCord Hospital during the period 1 March 2004 - 31 August 2005.
DESIGN: Observational cohort study.
SETTING: McCord Hospital, Durban, South Africa.
SUBJECTS: Antenatal patients attending the PMTCT clinic. MEASUREMENTS AND
RESULTS: During the 18 months all 2 624 women (100%) attending the antenatal clinic received HIV counselling, resulting in 91% (2 388) being tested for HIV. The prevalence of HIV in the total cohort was 13% (95% confidence interval (CI) 11.6 - 14.2). Of the HIV-positive mothers 302 (89%) completed their pregnancy at the hospital, and in this group there were 3 intrauterine deaths, 1 miscarriage, 1 maternal death (with the baby in utero) and 297 live births with 1 early neonatal death. Only 11% (36 out of 338) were lost to follow-up. A quarter (668) of the partners of all women attending the antenatal clinic were tested for HIV. Delivery in 70% (209) of live births was by caesarean section. Nevirapine was administered to 98% (290) of live babies and 75% (224) received zidovudine (AZT) as well. The 6-week polymerase chain reaction (PCR) baby test uptake was 81% (239 out of 296 live babies). Of those tested, 2.9% (95% CI 1.3 - 6.2) tested HIV positive.
CONCLUSION: Despite challenges faced by PMTCT providers in a resource-constrained setting, this state-aided hospital provides a comprehensive and integrated service and has achieved outcomes that compare favourably with those in the developed world.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18683379

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

Review 1.  Family-centred approaches to the prevention of mother to child transmission of HIV.

Authors:  Theresa S Betancourt; Elaine J Abrams; Ryan McBain; Mary C Smith Fawzi
Journal:  J Int AIDS Soc       Date:  2010-06-23       Impact factor: 5.396

Review 2.  Safer conception interventions for HIV-affected couples: implications for resource-constrained settings.

Authors:  Rachelle J Chadwick; Joanne E Mantell; Jennifer Moodley; Jane Harries; Virginia Zweigenthal; Diane Cooper
Journal:  Top Antivir Med       Date:  2011-11

3.  Pediatric treatment 2.0: ensuring a holistic response to caring for HIV-exposed and infected children.

Authors:  Shaffiq M Essajee; Stephen M Arpadi; Eric J Dziuban; Raul Gonzalez-Montero; Shirin Heidari; David G Jamieson; Scott E Kellerman; Emilia Koumans; Atieno Ojoo; Emilia Rivadeneira; Stephen A Spector; Helena Walkowiak
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

4.  Developing quality indicators for the care of HIV-infected pregnant women in the Dutch Caribbean.

Authors:  Hillegonda S Hermanides; Lonneke A van Vught; Ralph Voigt; Fred D Muskiet; Aimée Durand; Gerard van Osch; Sharline Koolman-Wever; Isaac Gerstenbluth; Colette Smit; Ashley J Duits
Journal:  AIDS Res Ther       Date:  2011-09-22       Impact factor: 2.250

5.  Outcome of HIV-exposed uninfected children undergoing surgery.

Authors:  Jonathan S Karpelowsky; Alastair J W Millar; Nelleke van der Graaf; Guido van Bogerijen; Heather J Zar
Journal:  BMC Pediatr       Date:  2011-07-29       Impact factor: 2.125

6.  Married men's perceptions of barriers for HIV-positive pregnant women accessing highly active antiretroviral therapy in rural Uganda.

Authors:  Putu Duff; Tom Rubaale; Walter Kipp
Journal:  Int J Womens Health       Date:  2012-05-16

Review 7.  The uptake of integrated perinatal prevention of mother-to-child HIV transmission programs in low- and middle-income countries: a systematic review.

Authors:  Lorainne Tudor Car; Serena Brusamento; Hoda Elmoniry; Michelle H M M T van Velthoven; Utz J Pape; Vivian Welch; Peter Tugwell; Azeem Majeed; Igor Rudan; Josip Car; Rifat Atun
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.